Tofranil (Imipramine) – Patient Information (UK)

Tofranil is a brand of imipramine, a medicine from the group of tricyclic antidepressants (TCAs). It has been used for many years to treat depression and, in some cases, specific conditions such as bedwetting (enuresis) in children. This page explains what Tofranil is, how it works, how it’s used, and important safety information.

Always follow the instructions provided with your medicine and discuss any concerns with a healthcare professional. If you experience severe side effects or signs of an emergency (for example, fainting, chest pain, or thoughts of self-harm), seek urgent medical help.

Quick facts

• Medicine: Tofranil (imipramine)
• Class: Tricyclic antidepressant (TCA)
• Main uses: Depression; some types of bedwetting (enuresis)
• How long it takes: Often 2–4 weeks for antidepressant benefit
• Common timing: Usually taken once daily, often in the evening for bedwetting; depression dosing may vary
• Important cautions: Heart rhythm effects, sedation, dry mouth, and drug interactions

Basic product information

How Tofranil works (mechanism of action)

Imipramine works by changing the levels and actions of certain chemicals in the brain, particularly serotonin and noradrenaline. It helps rebalance neurotransmission, which can improve mood and relieve some symptoms of depression.

It also has other effects on receptors involved in mood, pain modulation, and bladder function. These additional actions help explain why imipramine may help with specific conditions such as nocturnal enuresis (bedwetting).

• Monoamine reuptake inhibition: increases serotonin and noradrenaline signalling
• Receptor effects: influences histamine, alpha-adrenergic, and other receptor pathways
• Anticholinergic properties: may contribute to dry mouth, constipation, and sometimes reduced bladder overactivity

Pharmacokinetics (how the body handles imipramine)

Pharmacokinetics describes absorption, distribution, metabolism, and elimination. Understanding these processes can help you anticipate timing, side effects, and the importance of avoiding interactions.

• Absorption: Imipramine is absorbed through the gut after tablet administration.
• Distribution: It spreads through body tissues and crosses into the brain where it exerts its antidepressant effect.
• Metabolism: Primarily metabolised in the liver (largely via cytochrome enzymes). This is a key reason why other medicines that affect liver enzymes can change imipramine levels.
• Elimination: The medicine and its metabolites are removed mainly through the kidneys and through bile/fecal pathways depending on the metabolite profile.
• Half-life: Imipramine has a relatively long presence in the body compared with some newer antidepressants, meaning missed doses may not immediately disappear and stopping suddenly can lead to noticeable effects for some people.

Practical takeaway: Because it remains in the body for a while and is metabolised by the liver, dose changes should be gradual and drug interactions should be checked before starting new medicines.

What it’s used for (indications)

Tofranil (imipramine) is used for:

• Depression in adults, especially when a TCA is considered appropriate by a clinician.
• Nocturnal enuresis (bedwetting) in children and adolescents in selected cases, where other approaches have not been sufficient. Treatment should follow a structured clinical plan that includes behavioural and fluid-management advice.

The exact suitability depends on the person’s age, health history, and the nature of the symptoms. A clinician will assess benefits versus risks, particularly for children and for anyone with heart disease or risk factors.

When and how to take Tofranil (timing)

The dosing schedule depends on the reason for use, your age, and how you respond to treatment. Many people take imipramine once daily, but sometimes it may be divided.

• Depression: Often taken once daily in the evening to reduce daytime drowsiness, though exact timing varies by prescriber and patient response.
• Bedwetting (enuresis): Commonly taken in the evening, closer to bedtime, because it’s intended to help control overnight symptoms.
• Consistency matters: Try to take it at the same time each day.
• Give it time: For depression, improvement typically takes weeks rather than days.

Missed dose: If you miss a dose, follow the guidance on the medicine label. In general, do not take a double dose to make up for it. If you’re unsure, ask a pharmacist.

Typical dosing information

Doses vary widely depending on the condition being treated, age, and tolerance. Below is general guidance to help you understand how dosing often works; your own regimen may differ.

Adults – depression

• Starting dose: Often lower initially to reduce side effects, with gradual adjustment.
• Maintenance dose: Adjusted based on response and tolerability.
• Maximum dose: The upper limit depends on the product strength and clinical judgement; do not exceed it.

Children and adolescents – nocturnal enuresis

• Clinical assessment: Children should be assessed for underlying causes of bedwetting before starting medicine-based treatment.
• Weight/age considerations: Dosing is typically tailored to the child and guided by clinical instructions.
• Night-time focus: Dose timing is usually in the evening/at bedtime.
• Treatment review: Ongoing benefit should be reviewed regularly, and the medicine should not be continued indefinitely without reassessment.

Important: Because TCAs can be dangerous in overdose and can affect heart rhythm, dosing must be handled carefully. If you have been given a specific dose plan, follow it exactly and never change dose without advice.

Food interactions

In many people, food does not dramatically change imipramine’s overall effect, but individual absorption and stomach tolerance can vary. If you get nausea or stomach upset, taking the medicine after food may help.

• With meals: Many patients find taking it after a meal reduces stomach discomfort.
• Consistency: Keep your routine steady (for example, take it with dinner if that’s how you started).
• Grapefruit and similar products: Because imipramine is metabolised by the liver, any strong CYP-modifying substances should be discussed with a pharmacist/clinician. (Grapefruit is commonly used as an example of a substance that can interact with some medicines.)

If you have dietary restrictions or take supplements (including herbal products), ask a pharmacist to check for interactions.

Alcohol and medicine interactions

Alcohol

It’s strongly advised to avoid alcohol while taking Tofranil unless a healthcare professional has said it’s acceptable. Alcohol can worsen common side effects such as:

• drowsiness and dizziness
• slowed reaction time
• impaired coordination (increasing fall risk)
• mood changes

Alcohol combined with TCAs can also increase the risk of serious complications, including effects on heart rhythm and overall sedation.

Other medicines (key interaction categories)

Imipramine interacts with several medicines. Tell your healthcare professional about all medicines you take, including:

• prescription medicines
• over-the-counter medicines
• herbal products and supplements

Common clinically important interaction categories include:

• Other antidepressants, especially SSRIs/SNRIs: may raise imipramine levels and increase side effects.
• MAO inhibitors: serious interactions can occur if used close together. A safe interval is essential.
• Medicines that affect heart rhythm (QT-prolonging medicines): combined risk may increase.
• Medicines that affect liver enzymes: can alter imipramine metabolism and blood levels.
• Medicines that increase sedation (some antihistamines, sleeping tablets, opioid pain medicines): may increase drowsiness and breathing risks in vulnerable individuals.
• Anticholinergic medicines: can add to dry mouth, constipation, blurred vision, and urinary retention.

Medication review tip: If you start, stop, or change any medicine, check interactions—especially during the first weeks of treatment.

Safety profile: common and serious side effects

Like all medicines, Tofranil can cause side effects. Many are manageable, and symptoms often improve as your body adjusts. However, some effects need prompt medical attention.

Common side effects

• Drowsiness or fatigue
• Dizziness, especially when standing up (orthostatic hypotension)
• Dry mouth
• Constipation
• Blurred vision
• Increased sweating
• Weight change in some people
• Changes in appetite
• Tremor or restlessness in some cases
• Sexual function changes (variable by person)

Serious side effects (seek urgent help)

• Signs of an allergic reaction such as facial swelling, trouble breathing, or severe rash.
• Fainting, severe dizziness, or symptoms suggesting significant low blood pressure.
• Chest pain, palpitations, or heartbeat irregularities (especially if you feel unwell).
• Severe confusion, high fever, muscle stiffness, or agitation (could indicate rare but serious reactions).
• Thoughts of self-harm or sudden worsening mood—contact urgent medical support promptly.

Overdose warning

TCAs such as imipramine can be dangerous in overdose. Keep your medicine out of reach of children, and never take extra tablets to “catch up.” If an overdose is suspected, seek emergency help immediately.

Practical use tips for safer, smoother treatment

• Start low, go slow: Dose adjustments are often gradual to reduce side effects.
• Rise slowly: If you feel light-headed, sit up and stand gradually.
• Manage dry mouth: Sip water, choose sugar-free sweets/gum, and maintain oral hygiene.
• Prevent constipation: Increase fluid and fibre intake where appropriate; ask a pharmacist about suitable remedies.
• Driving and machinery: Because drowsiness can occur, avoid driving or operating machinery until you know how Tofranil affects you.
• Keep alcohol in mind: Avoid alcohol to reduce dizziness and safety risks.
• Don’t stop suddenly: If you need to stop, follow a gradual plan agreed with a clinician to minimise withdrawal-like symptoms.
• Monitor wellbeing: If mood worsens, anxiety increases, or you feel agitated, seek advice promptly.
• For bedwetting: Combine the medicine plan with practical strategies (night-time routines, regular toileting, and behavioural support) for best results.

Withdrawal and stopping (what to expect)

People sometimes experience symptoms when stopping TCAs, especially if stopped abruptly. These can include nausea, headache, sleep disturbance, irritability, and a return or worsening of the original condition.

The safest approach is usually to reduce the dose gradually under healthcare guidance. If you’re considering stopping because of side effects or lack of benefit, talk to a healthcare professional rather than stopping on your own.

Alternative options

Depending on the condition being treated, there may be other medicines and strategies that can be considered. Alternatives for depression and bedwetting can differ significantly.

Depression alternatives

• SSRIs/SNRIs (commonly used first-line options for many people)
• Other antidepressants (choice depends on symptoms and health profile)
• Psychological therapies (for example, talking therapies), sometimes alongside medication

Nocturnal enuresis alternatives

• Behavioural strategies (bedtime routines, scheduled toilet visits, fluid timing)
• Desmopressin in selected cases
• Assessing contributing factors such as constipation, sleep quality, and urinary tract issues

Your clinician will choose options based on age, medical history, and risk factors (especially for heart rhythm concerns with TCAs).

UK market and legal context (what matters for patients)

In the United Kingdom, antidepressants and other psychoactive medicines are subject to regulation regarding safe supply, appropriate use, and pharmacy oversight. Medicines such as imipramine are supplied under established UK healthcare frameworks, and pharmacists play an important role in checking suitability and interactions.

Key UK-related points for patients include:

• Safety monitoring: People starting or changing antidepressant therapy may require follow-up for early side effects and mood changes.
• Vulnerable groups: Children and adolescents need careful assessment and appropriate monitoring, particularly for behavioural and emotional wellbeing.
• Cardiac risk awareness: TCAs can affect cardiac conduction in some circumstances; clinicians may consider risk factors and, where appropriate, monitoring.
• Quality and supply: Pharmacy supply is regulated to ensure medicines meet the required standards.

Guidance and recommendations for depression and enuresis can change over time based on ongoing evidence. Your healthcare professional can advise on the most current approach for your situation.

Recent guidance and important clinical considerations (UK-relevant)

While specific local recommendations may vary, the following themes are consistent with UK clinical approaches:

• Early review: People starting antidepressant therapy typically benefit from early follow-up to assess tolerability and symptom change.
• Age-related caution: Young people (especially children and adolescents) require careful monitoring for changes in mood, agitation, or self-harm thoughts.
• Heart safety: TCAs are considered when appropriate, but clinicians weigh benefits against risks such as cardiovascular disease and potential drug interactions.
• Enuresis plans: Medicine for bedwetting is usually part of a broader plan including behavioural strategies and assessment for contributing factors.

If you’re unsure whether Tofranil is the right option for you, or you want to understand monitoring you should expect, ask your pharmacist or clinician.

Delivery and availability in the UK

Availability of Tofranil (imipramine) can vary by strength and formulation due to manufacturer supply cycles and pharmacy stock levels. Many online pharmacies support UK-wide delivery for eligible medicines.

• Dispatch times: Commonly same-day or next-working-day dispatch when stock is available.
• Delivery service: Usually standard or tracked delivery options are offered at checkout.
• Stock alerts: Some pharmacies may offer notifications if a product becomes available again.
• Packaging: Medicines are typically supplied in original manufacturer packaging where possible.

When ordering, ensure your address and contact details are correct. If you need urgent assistance due to treatment interruption, contact the pharmacy promptly.

FAQ – Tofranil (imipramine)

1) How long does it take for Tofranil to work?

For depression, some improvement may be noticed within 2–4 weeks, though full benefit can take longer. For nocturnal enuresis, changes may be seen more quickly, but ongoing assessment is important.

2) Will Tofranil make me sleepy?

Yes, drowsiness is common. Taking it in the evening may help reduce daytime sleepiness. Avoid driving or risky activities until you know how you respond.

3) Can I take Tofranil with food?

Many people can take it with or without food. If it upsets your stomach, taking it after meals may be easier. Keep your routine consistent and follow the instructions on your label.

4) What should I avoid while taking imipramine?

Avoid alcohol and be careful with other medicines that cause sedation or affect heart rhythm. Always check interactions when starting any new medicine, including over-the-counter products and herbal supplements.

5) Can I stop Tofranil suddenly?

It’s generally not recommended to stop suddenly. A gradual reduction helps reduce the chance of unpleasant discontinuation symptoms and may reduce the risk of symptoms returning. Seek advice before stopping.

6) Are there any heart-related reasons to be cautious?

Tricyclic antidepressants can affect heart conduction in some people. Extra care is needed if you have existing heart disease, a history of rhythm problems, or if you take medicines that can affect the heart’s electrical activity. Your pharmacist or clinician can advise based on your profile.

7) What if I miss a dose?

Follow the guidance on your medicine label. Typically, do not take a double dose. If you’re unsure, ask your pharmacist for advice tailored to your dosing schedule.

8) Is Tofranil suitable for children?

Imipramine may be used for nocturnal enuresis in children under a structured clinical plan. Dosing and monitoring are age- and situation-specific, and it should not be used without appropriate assessment.

9) What about constipation and dry mouth?

These are common anticholinergic effects. Increase fluids, maintain fibre intake, and seek advice for constipation if it becomes troublesome. For dry mouth, try frequent sips of water, sugar-free oral products, and good oral hygiene.

10) Are there alternatives if I can’t tolerate Tofranil?

Yes. Alternatives may include other antidepressants or therapies for depression, and different strategies or medicines for bedwetting. Discuss your symptoms and side effects with a healthcare professional to find the best option.

Need help choosing or understanding your medicine?

If you have questions about how to take Tofranil, managing side effects, or possible interactions with your existing medicines, speak to a qualified healthcare professional or pharmacist. They can help you make informed decisions based on your personal medical history.